APA (7th ed.) Citation

Wang, C., Li, X., Zhang, J., Ge, Z., Chen, H., & Hu, J. (2018). EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression. OncoTargets & Therapy, 11, 7853. https://doi.org/10.2147/OTT.S180131

Chicago Style (17th ed.) Citation

Wang, Chenyu, Xingwang Li, Junjie Zhang, Zheng Ge, Hejin Chen, and Junhong Hu. "EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression." OncoTargets & Therapy 11 (2018): 7853. https://doi.org/10.2147/OTT.S180131.

MLA (9th ed.) Citation

Wang, Chenyu, et al. "EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression." OncoTargets & Therapy, vol. 11, 2018, p. 7853, https://doi.org/10.2147/OTT.S180131.